DUPONT CAPITAL MANAGEMENT CORP - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 206 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.

Quarter-by-quarter ownership
DUPONT CAPITAL MANAGEMENT CORP ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$373,000
+30.9%
23,907
-20.7%
0.01%
+33.3%
Q3 2020$285,000
-1.0%
30,155
-6.3%
0.01%0.0%
Q2 2020$288,000
-2.7%
32,175
-30.7%
0.01%
-14.3%
Q1 2020$296,000
-23.9%
46,4590.0%0.01%
-22.2%
Q4 2019$389,000
+35.1%
46,459
+45.9%
0.01%
+28.6%
Q3 2019$288,000
+11.6%
31,844
+134.4%
0.01%
+16.7%
Q1 2018$258,00013,5830.01%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
FIC CAPITAL INC 875,284$2,670,0001.34%
NEXTHERA CAPITAL LP 503,000$1,534,0000.90%
Opaleye Management Inc. 400,000$1,220,0000.72%
WASATCH ADVISORS LP 7,256,260$22,132,0000.33%
Cormorant Asset Management, LP 650,000$1,983,0000.27%
Sicart Associates LLC 101,950$311,0000.22%
Baker Brothers Advisors 4,055,876$12,370,0000.12%
Leisure Capital Management 43,008$131,0000.12%
Piermont Capital Management Inc. 165,569$505,0000.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 837,963$2,556,0000.10%
View complete list of SANGAMO THERAPEUTICS INC shareholders